236 related articles for article (PubMed ID: 30687326)
1. Understanding the Functional Properties of Neonatal Dendritic Cells: A Doorway to Enhance Vaccine Effectiveness?
Papaioannou NE; Pasztoi M; Schraml BU
Front Immunol; 2018; 9():3123. PubMed ID: 30687326
[TBL] [Abstract][Full Text] [Related]
2. Insight into the immunobiology of human skin and functional specialization of skin dendritic cell subsets to innovate intradermal vaccination design.
Teunissen MB; Haniffa M; Collin MP
Curr Top Microbiol Immunol; 2012; 351():25-76. PubMed ID: 21833835
[TBL] [Abstract][Full Text] [Related]
3. Adjuvants Enhancing Cross-Presentation by Dendritic Cells: The Key to More Effective Vaccines?
Ho NI; Huis In 't Veld LGM; Raaijmakers TK; Adema GJ
Front Immunol; 2018; 9():2874. PubMed ID: 30619259
[TBL] [Abstract][Full Text] [Related]
4. Understanding the murine cutaneous dendritic cell network to improve intradermal vaccination strategies.
Ginhoux F; Ng LG; Merad M
Curr Top Microbiol Immunol; 2012; 351():1-24. PubMed ID: 21058006
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses.
Dowling DJ; Scott EA; Scheid A; Bergelson I; Joshi S; Pietrasanta C; Brightman S; Sanchez-Schmitz G; Van Haren SD; Ninković J; Kats D; Guiducci C; de Titta A; Bonner DK; Hirosue S; Swartz MA; Hubbell JA; Levy O
J Allergy Clin Immunol; 2017 Nov; 140(5):1339-1350. PubMed ID: 28343701
[TBL] [Abstract][Full Text] [Related]
6. Targeting skin dendritic cells to improve intradermal vaccination.
Romani N; Flacher V; Tripp CH; Sparber F; Ebner S; Stoitzner P
Curr Top Microbiol Immunol; 2012; 351():113-38. PubMed ID: 21253784
[TBL] [Abstract][Full Text] [Related]
7. Engineering immunity: Modulating dendritic cell subsets and lymph node response to direct immune-polarization and vaccine efficacy.
Leleux J; Atalis A; Roy K
J Control Release; 2015 Dec; 219():610-621. PubMed ID: 26489733
[TBL] [Abstract][Full Text] [Related]
8. [Effect of neonatal BCG vaccination on phenotype and function of splenic dendritic cells of BALB/c mice].
Liu CH; Liu EM; Liu CH; Liu W; Yang XQ; Li X
Zhonghua Er Ke Za Zhi; 2008 Oct; 46(10):784-8. PubMed ID: 19099886
[TBL] [Abstract][Full Text] [Related]
9. Parenteral Vaccination Can Be an Effective Means of Inducing Protective Mucosal Responses.
Clements JD; Freytag LC
Clin Vaccine Immunol; 2016 Jun; 23(6):438-441. PubMed ID: 27122485
[TBL] [Abstract][Full Text] [Related]
10. Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccines.
De Serrano LO; Burkhart DJ
J Nanobiotechnology; 2017 Nov; 15(1):83. PubMed ID: 29149896
[TBL] [Abstract][Full Text] [Related]
11. [Dendritic cells of mucosa and skin: "recruited for vaccination"].
Le Borgne M; Dubois B; Kaiserlian D
Med Sci (Paris); 2007 Oct; 23(10):819-25. PubMed ID: 17937889
[TBL] [Abstract][Full Text] [Related]
12. Correlates of vaccine adjuvanticity, vaccine activity, protective immunity and disease in human infectious disease and cancer.
Ottenhoff THM
Semin Immunol; 2018 Oct; 39():1-3. PubMed ID: 30318307
[No Abstract] [Full Text] [Related]
13. NLRP3 in protective immunity and vaccination against respiratory infection.
Lavelle EC; McNaughton A; McNeela E
Expert Rev Vaccines; 2011 Mar; 10(3):255-7. PubMed ID: 21434793
[No Abstract] [Full Text] [Related]
14. Oral Delivery of Probiotics Expressing Dendritic Cell-Targeting Peptide Fused with Porcine Epidemic Diarrhea Virus COE Antigen: A Promising Vaccine Strategy against PEDV.
Wang X; Wang L; Huang X; Ma S; Yu M; Shi W; Qiao X; Tang L; Xu Y; Li Y
Viruses; 2017 Oct; 9(11):. PubMed ID: 29068402
[TBL] [Abstract][Full Text] [Related]
15. Boosting vaccine power.
Garçon N; Goldman M
Sci Am; 2009 Oct; 301(4):72-9. PubMed ID: 19780455
[No Abstract] [Full Text] [Related]
16. Dendritic cell targeted vaccines: Recent progresses and challenges.
Chen P; Liu X; Sun Y; Zhou P; Wang Y; Zhang Y
Hum Vaccin Immunother; 2016 Mar; 12(3):612-22. PubMed ID: 26513200
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cell development in infection.
Bieber K; Autenrieth SE
Mol Immunol; 2020 May; 121():111-117. PubMed ID: 32199210
[TBL] [Abstract][Full Text] [Related]
18. Targeting vaccines to dendritic cells.
Foged C; Sundblad A; Hovgaard L
Pharm Res; 2002 Mar; 19(3):229-38. PubMed ID: 11934227
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of dendritic cell-based vaccine potency by anti-apoptotic siRNAs targeting key pro-apoptotic proteins in cytotoxic CD8(+) T cell-mediated cell death.
Kim JH; Kang TH; Noh KH; Bae HC; Kim SH; Yoo YD; Seong SY; Kim TW
Immunol Lett; 2009 Jan; 122(1):58-67. PubMed ID: 19135479
[TBL] [Abstract][Full Text] [Related]
20. Enhanced effects of DNA vaccine against botulinum neurotoxin serotype A by targeting antigen to dendritic cells.
Chen BY; Zhou G; Li QL; Lu JS; Shi DY; Pang XB; Zhou XW; Yu YZ; Huang PT
Immunol Lett; 2017 Oct; 190():118-124. PubMed ID: 28802641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
